Bank of New York Mellon’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,559
Closed -$6K 4597
2022
Q3
$6K Hold
1,559
﹤0.01% 4532
2022
Q2
$10K Sell
1,559
-4,961
-76% -$46.3K ﹤0.01% 4551
2022
Q1
$74K Hold
6,520
﹤0.01% 4464
2021
Q4
$103K Buy
6,520
+101
+2% +$2.14K ﹤0.01% 4397
2021
Q3
$155K Sell
6,419
-111
-2% -$3.34K ﹤0.01% 4259
2021
Q2
$227K Buy
6,530
+429
+7% +$17.1K ﹤0.01% 4056
2021
Q1
$293K Sell
6,101
-1,285
-17% -$74.5K ﹤0.01% 3917
2020
Q4
$357K Buy
7,386
+1,460
+25% +$54.9K ﹤0.01% 3762
2020
Q3
$208K Buy
5,926
+1,026
+21% +$57.8K ﹤0.01% 3837
2020
Q2
$337K Buy
+4,900
New +$195K ﹤0.01% 3658
2019
Q2
Sell
-4,857
Closed -$67K 4309
2019
Q1
$67K Sell
4,857
-41
-0.8% -$475 ﹤0.01% 4064
2018
Q4
$40K Hold
4,898
﹤0.01% 4083
2018
Q3
$115K Sell
4,898
-3
-0.1% -$114 ﹤0.01% 4018
2018
Q2
$244K Buy
4,901
+727
+17% +$36K ﹤0.01% 3880
2018
Q1
$191K Sell
4,174
-88
-2% -$4.42K ﹤0.01% 3939
2017
Q4
$195K Buy
4,262
+52
+1% +$2.76K ﹤0.01% 3956
2017
Q3
$260K Buy
4,210
+1,220
+41% +$71.4K ﹤0.01% 3803
2017
Q2
$190K Buy
2,990
+1,976
+195% +$110K ﹤0.01% 3914
2017
Q1
$75K Sell
1,014
-18
-2% -$2K ﹤0.01% 4083
2016
Q4
$154K Buy
+1,032
New +$183K ﹤0.01% 3953

Other funds holding NH

Bank of New York Mellon's NH Position: Q4 2022 in Review

Bank of New York Mellon sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 1,559 shares — an estimated $6K sold.

Bank of New York Mellon first reported a position in NH in Q4 2016 and held it in 20 quarters. The position peaked at $357K in Q4 2020. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.

  • Bank of New York Mellon reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 1,559 NantHealth, Inc shares in Q4 2022, an estimated $6K.
  • Bank of New York Mellon first reported a position in NantHealth, Inc in Q4 2016 and held it in 20 quarters.
  • Bank of New York Mellon's NantHealth, Inc position peaked at $357K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.